Cart
sales@molnova.com
4-Bromomethyl-2-cyanobiphenyl
CAS No. 114772-54-2
4-Bromomethyl-2-cyanobiphenyl( —— )
Catalog No. M19899 CAS No. 114772-54-2
4’-Bromomethyl-2-cyanobiphenyl is a halogenated benzonitrile used in protein-binding studies of quinoxaline angiotensin II receptor antagonists.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 10MG | 29 | In Stock |
|
| 25MG | 46 | In Stock |
|
| 50MG | 65 | In Stock |
|
| 100MG | 96 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 216 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name4-Bromomethyl-2-cyanobiphenyl
-
NoteResearch use only, not for human use.
-
Brief Description4’-Bromomethyl-2-cyanobiphenyl is a halogenated benzonitrile used in protein-binding studies of quinoxaline angiotensin II receptor antagonists.
-
Description4’-Bromomethyl-2-cyanobiphenyl is a halogenated benzonitrile used in protein-binding studies of quinoxaline angiotensin II receptor antagonists.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number114772-54-2
-
Formula Weight272.14
-
Molecular FormulaC14H10BrN
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESBrCc1ccc(cc1)-c1ccccc1C#N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Apraglutide TFA (129...
Apraglutide TFA (FE 203799 TFA), a synthetic 33-amino-acid peptide and a long-acting GLP-2 analogue, enhances adaptation and linear intestinal growth in a neonatal piglet model of short bowel syndrome with total resection of the ileum.
-
Disinomenine
1,1′-Disinomenine is an alkaloid that can be isolated from the stems of Sinomenium acutum. 1,1′-Disinomenine shows weak inhibition against A549 and Hela cells.
-
fulvotomentoside A
Fulvotomentoside A could decrease overexpression of IL-6 and IL-17A, and increase the expression of specific transcription factor Foxp3 of regulatory T cells significantly in intestine.
